Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

This study has been completed.
Gilead Sciences
Information provided by:
University of Washington Identifier:
First received: September 12, 2005
Last updated: November 14, 2007
Last verified: November 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Estimated Primary Completion Date: No date given